Sour times for drug makers

Published: 2012-05-02 06:59:00

Updated: 2012-05-02 06:59:00

Korea’s pharmaceutical companies are feeling another pain under government pressure to refrain from raising OTC (over-the-counter) prices despite soaring oil prices, industry sources said yesterday.

The price of pharmaceuticals prescribed by doctors fell by 14 percent on average from April 1....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK